CONTACT US 0845 345 5004
  • being awesome
  • new-bnnr-3
  • new-bnnr-2
  • new-bnnr-4
  • new-bnnr-5-1

Latest Blogs

Crowdfunding and Nominee Shareholdings

crowdfunding
Crowdfunding’s use has grown significantly in recent years to the point where it is now a common method of fund raising for early stage and growth companies. The regulation around crowdfunding is still relatively new and the FCA opened a consultation on the rules around loan-based crowdfunding back in July of this year, an example of how rapidly crowdfunding is expanding. ‘Equity-based’ crowdfunding is the form that most will be familiar with. This is where the ‘crowd’ invests through a large amount of individuals, each investing a relatively small amount in return for shares. Crowdfunding can be an invaluable tool for...
Continue reading
  689 Hits
689 Hits

New funding to support global fight against C. difficile

MBM Commercial recently assisted with Archangels’ investment in MGB Biopharma to support the global fight against C. difficile . A novel anti-bacterial agent which has been developed in Scotland by MGB Biopharma (MGB) for the treatment of Clostridium difficile infections, is to enter Phase II clinical trials following a newly-completed £1.3m fund raise from existing and new investors, supplementing a £2.7m grant awarded earlier this year by Innovate UK.  MGB’s lead drug, MGB-BP-3 was invented at the University of Strathclyde, Glasgow, and will now be tested in patients for the first time in the fight against Clostridium difficile-associated disease (CDAD). MGB-BP-3...
Continue reading
  612 Hits
612 Hits

Another year, another (Converge) Challenge

converge front cover
converge participants
Converge Challenge has been a fantastic programme this year with some truly inspiring businesses coming through the programme. We have been very lucky to be involved and impressed by the market research, commercial awareness and technological innovation demonstrated by the Converge Challenge participant companies. It has been a real pleasure working with the cohort on business plans and legal issues. As part of MBM Commercial’s sponsorship of the programme, our Alexander Lamley has been attending legal clinics to help the Converge companies identify and address early stage issues. As a start-up business there are some essential things to think about when...
Continue reading
  732 Hits
732 Hits

MBM Commercial enters strategic partnership for patent attorney consultants

partnership
  MBM Commercial is delighted to welcome two new European patent attorney consultants to the team as part of a strategic partnership with entrepreneurial patent attorney firm, Ellis IP. Dr. Michael Ellis and Dr. Claudia Duffy are experienced European patent attorneys with a focus on advising entrepreneurial businesses throughout the UK. MBM Commercial has a strong reputation as a leading legal adviser throughout the UK to investors and high growth technology companies and this strategic partnership expands the firm’s intellectual property and corporate finance capability.  Working alongside the firm’s IP, Data & Contracts Team and its Corporate Team, the patent attorney...
Continue reading
  845 Hits
845 Hits

The view from London

We live in strange times.  Perhaps it is a product of our Britishness that we appear to have our heads firmly in the sand about the impending departure from the European Union.  Some people still think that Brexit will not happen; some have accepted (or embraced) the fact that we are leaving the EU, but many of them have seen that the world has continued much the same since the referendum.  They don’t seem to have grasped that triggering Article 50 is only the prelude.  Brexit is what is going to happen in March 2019.  Ready or not. We are of...
Continue reading
  596 Hits
596 Hits

Contact us

Invalid Input
Invalid Input
Invalid Input
Invalid Input
Invalid Input
You must confirm you have read and accept our Website Privacy Policy.
Invalid Input